Today: 7 February 2026
Subscribe
Browse Category

Health Insurance News 10 November 2025 - 11 December 2025

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health, Inc. (NYSE: OSCR) is back under the market’s spotlight on December 11, 2025, as Wall Street adds new coverage, doubles down on long‑term profit targets, and investors digest another bout of volatility in this high‑growth, high‑risk health‑insurtech name. While legacy giants such as American International Group, Inc. (AIG) dominate traditional insurance lines, Oscar is trying to reinvent health coverage for the Affordable Care Act (ACA) era with a tech‑first platform, AI tools, and aggressive geographic expansion. That experiment is playing out in real time in the stock price. Oscar Health stock today: volatile in the mid‑$15s As of
11 December 2025
···
Oscar Health (OSCR) Stock: Can a 35% Rally Survive Fresh Downgrades and ACA Uncertainty? – December 7, 2025

Oscar Health (OSCR) Stock: Can a 35% Rally Survive Fresh Downgrades and ACA Uncertainty? – December 7, 2025

Oscar Health Inc. (NYSE: OSCR) has just delivered one of the wildest weeks in its short public-market life: the stock jumped roughly 35% on hopes that the White House will extend Affordable Care Act (ACA) subsidies, then ran straight into a wall of new downgrades and rising bearish options activity. Investopedia+2Reuters+2 As of the latest close, Oscar shares trade around $16.77, giving the health-tech insurer a market value of roughly $4.4–4.5 billion. That leaves the stock about 30% below its 52‑week high of $23.80 and roughly 50% above its 52‑week low of $11.20. StockAnalysis+1 Below is a deep dive into
7 December 2025
·····
Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Date: December 4, 2025Ticker: Humana Inc. (NYSE: HUM) Humana’s share price spent most of 2025 behaving like a stressed-out cardiogram: sharp drops around guidance cuts and star-rating headlines, then sharp rebounds when the numbers looked less bad than feared. As of early trading on December 4, Humana stock is changing hands in the mid‑$250s, down roughly 12% over the past year and about 18% below its 52‑week high of $315.35 reached in September. Year to date, the stock is barely positive, up just over 1%, and significantly lagging the SPDR S&P Health Care Services ETF, which has returned almost 20%
4 December 2025
···
Mumbai Consumer Commission Orders Niva Bupa To Pay ₹66.5 Lakh For Overseas Cancer Treatment: What The Landmark Ruling Means For Health Insurance Customers

Mumbai Consumer Commission Orders Niva Bupa To Pay ₹66.5 Lakh For Overseas Cancer Treatment: What The Landmark Ruling Means For Health Insurance Customers

The Mumbai Suburban District Consumer Disputes Redressal Commission has directed Niva Bupa Health Insurance Company Ltd to pay ₹66.5 lakh to a Juhu-based cancer patient after holding that the insurer wrongfully cancelled his policy and denied his overseas treatment claim. The order, now widely reported across legal and financial media as of December 4, 2025, is being described as one of the most significant consumer wins in health insurance in recent years. Live Law+1 Multiple outlets including LiveLaw, Hindustan Times, The Times of India, Moneylife, Free Press Journal, Outlook Money and others have highlighted how the commission called out “unfair
4 December 2025
·
UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth Group Incorporated (NYSE: UNH) heads into the final weeks of 2025 as one of the most watched – and most controversial – stocks in the Dow. As of the last trading session on Friday, November 28, UnitedHealth closed around $329.77 per share, implying a market capitalization of roughly $299 billion. StockAnalysis That price comes after a brutal year: UNH’s year‑to‑date return is around –34.6% and its one‑year total shareholder return is about –44.8%, according to fresh analysis published today by Simply Wall St. Simply Wall St Yet, in the last week the stock has actually risen about 3%, putting
30 November 2025
····
UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group Incorporated (NYSE: UNH) has gone from defensive market darling to one of 2025’s most controversial blue‑chips. As of 29 November 2025, the stock is trading around $330 per share, down roughly 45% over the past year, even after a modest rebound in late November.StockAnalysis+1 At the same time, the company is raising its full‑year earnings outlook, reshaping its Medicare Advantage business, facing a high‑profile U.S. Department of Justice (DOJ) investigation and adding former FDA commissioner Scott Gottlieb to its board. grassley.senate.gov+3UnitedHealth Group+3UnitedHealth Group+3 This overview pulls together the main UNH headlines investors are digesting as of 29 November
29 November 2025
···
UnitedHealth Group (UNH) Stock: What to Watch Before the November 28, 2025 Open

UnitedHealth Group (UNH) Stock: What to Watch Before the November 28, 2025 Open

UnitedHealth Group Incorporated (NYSE: UNH) heads into Friday’s shortened Black Friday session still carrying one of the ugliest year‑to‑date charts in the Dow – and some of the heaviest policy and legal baggage in the U.S. healthcare sector. After a brutal sell‑off driven by soaring medical costs, a massive cyberattack and a federal investigation into Medicare billing, UnitedHealth stock has clawed back from its lows but remains down roughly one‑third so far in 2025 and more than 40% over the past 12 months. FinanceCharts+1 With U.S. markets reopening Friday after Thanksgiving and closing early at 1 p.m. ET, investors will
28 November 2025
···
Oscar Health (OSCR) Stock Soars on Piper Sandler Upgrade and ACA Tailwinds – What to Know on November 26, 2025

Oscar Health (OSCR) Stock Soars on Piper Sandler Upgrade and ACA Tailwinds – What to Know on November 26, 2025

Oscar Health, Inc. (NYSE: OSCR) is surging again today. As of mid‑afternoon trading on Wednesday, November 26, 2025, Oscar Health stock is trading around $18.20, up roughly 8–9% on the day, after moving between about $16.20 and $18.60 in today’s session. Timothy Sykes+1 The move extends an already powerful run: shares are up roughly 25% over the past week, driven by a combination of bullish analyst calls and improving policy visibility around Affordable Care Act (ACA) subsidies. Benzinga Below is a detailed, news‑driven look at why Oscar Health stock is rallying today, what analysts are saying, how the latest numbers
26 November 2025
··
UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group Incorporated (NYSE: UNH) shares are edging higher today as investors digest fresh policy headlines out of Washington and a wave of new analysis explaining how the stock managed to lose roughly half its value over the past year. By early afternoon, UNH is trading around $322 per share, up about 0.6% on the day, with an intraday range near $318–$329 and a market value just under $292 billion.StockAnalysis That’s still almost 50% below its 52‑week high of about $623, underscoring how severe 2025’s selloff has been.StockAnalysis+1 At the same time, a new Reuters report that the Trump administration
24 November 2025
····
Medicare 2026 Premiums Jump Nearly 10%: How Much of Your 2.8% Social Security COLA Will You Actually Keep?

Medicare 2026 Premiums Jump Nearly 10%: How Much of Your 2.8% Social Security COLA Will You Actually Keep?

As of today, November 24, 2025, the picture for retirees in 2026 is getting clearer — and more expensive. The Centers for Medicare & Medicaid Services (CMS) has confirmed that standard Medicare Part B premiums will rise nearly 10% next year, from $185.00 in 2025 to $202.90 in 2026, while the annual deductible will climb from $257 to $283. CMS+1 At the same time, the Social Security Administration has finalized a 2.8% cost-of-living adjustment (COLA) for 2026, lifting the average monthly retirement benefit from $2,015 to about $2,071 — a gain of roughly $56. Social Security+1 Put together, multiple analyses
24 November 2025
···
Centene (CNC) Slides on ACA-Subsidy Uncertainty as Wellcare Expands in Texas and Ambetter Adds South Carolina Plans — Nov. 10, 2025

Centene (CNC) Slides on ACA-Subsidy Uncertainty as Wellcare Expands in Texas and Ambetter Adds South Carolina Plans — Nov. 10, 2025

Market snapshot As of 14:48 UTC on Nov. 10, CNC traded at $33.91 (intraday range $33.64–$36.09). Why CNC is under pressure today In posts over the weekend, President Donald Trump called for redirecting “hundreds of billions” in ACA subsidy funds directly to consumers, rather than to insurers. By early Monday, managed-care stocks with ACA exposure, including Centene, were lower in premarket trading. Reuters notes the comments land amid a 40‑day federal government shutdown and renewed debate over enhanced ACA subsidies set to expire Dec. 31, a program that has helped double ACA enrollment to ~24 million since 2021. Reuters Company
10 November 2025
Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health (OSCR) launches 2026 South Florida plans, adds ‘HelloMeno’; stock in focus — Nov. 10, 2025

Oscar Health, Inc. (NYSE: OSCR) announced new individual-market plans for South Florida ahead of the 2026 Open Enrollment window and spotlighted HelloMeno, a menopause-focused offering it and partner Elektra Health describe as the first plan of its kind in the individual market. The rollout lands as Washington headlines around ACA premium tax credits pressure managed-care shares broadly; investors are watching OSCR’s intraday action closely. Business Wire+2PR Newswire+2 Key takeaways What Oscar announced today Oscar said it will offer new, affordable individual‑market plans across South Florida for plan year 2026, with options available in Miami‑Dade, Broward, Palm Beach, Martin, and St.
10 November 2025
···
1 … 4 5 6 7

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop